More about

Interstitial Lung Disease

News
November 08, 2020
3 min read
Save

Multidisciplinary team key to ‘rethinking approach to ILD in pregnancy’

Multidisciplinary team key to ‘rethinking approach to ILD in pregnancy’

Close monitoring by a multidisciplinary team may allow pregnant women with interstitial lung disease secondary to autoimmune disease to avoid terminating their pregnancy, according to a presenter at ACR Convergence 2020 virtual meeting.

News
October 16, 2020
2 min read
Save

'Evolving' understanding of disease biology may expand CTD-ILD therapy options

'Evolving' understanding of disease biology may expand CTD-ILD therapy options

Further understanding of connective tissue disease-associated interstitial lung disease has opened doors for therapeutic options, but more work needs to be done in the field, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.

News
October 12, 2020
3 min read
Save

'Multidisciplinary approach' strongly encouraged in systemic sclerosis

'Multidisciplinary approach' strongly encouraged in systemic sclerosis

A multidisciplinary approach is key to optimizing outcomes in systemic sclerosis, given the broad range of manifestations and organ systems that may be involved, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.

News
October 09, 2020
1 min read
Save

ILD a risk factor for poor outcomes from COVID-19

ILD a risk factor for poor outcomes from COVID-19

Older adults with interstitial lung disease and COVID-19 have increased risk for severe disease, hospitalization and death, researchers reported in the American Journal of Respiratory and Critical Care Medicine.

News
October 01, 2020
2 min read
Save

Connective tissue disease-related ILD leads to significant workplace productivity loss

Connective tissue disease-related ILD leads to significant workplace productivity loss

In a new study, 59% of patients with connective tissue disease-related interstitial lung disease reported significant workplace productivity loss unexplained by symptoms or lung physiology.

News
September 01, 2020
2 min read
Save

Top pulmonology news in August: COVID-19 and air quality, vitamin D for asthma and more

Top pulmonology news in August: COVID-19 and air quality, vitamin D for asthma and more

The Healio editors have compiled a list of the most-read pulmonology news published in August.

News
August 27, 2020
2 min read
Save

ATS guideline addresses challenges in diagnosing hypersensitivity pneumonitis

ATS guideline addresses challenges in diagnosing hypersensitivity pneumonitis

The American Thoracic Society issued a new clinical practice guideline to aid clinicians in diagnosing hypersensitivity pneumonitis in patients with newly diagnosed interstitial lung disease — the first new guidance in 3 decades.

News
August 19, 2020
2 min read
Save

Recent updates in pulmonary hypertension: New treatment options, inhaled therapy and more

Recent updates in pulmonary hypertension: New treatment options, inhaled therapy and more

The Healio editors have compiled a list of recent updates in the management and treatment of pulmonary hypertension.

News
August 14, 2020
2 min read
Save

Nintedanib analyses support benefit in chronic fibrosing ILDs with progressive phenotype

Nintedanib analyses support benefit in chronic fibrosing ILDs with progressive phenotype

New analyses of the INBUILD trial show nintedanib slowed lung function decline and reduced the annual rate of FVC decline in patients with a progressive form of chronic fibrosing interstitial lung diseases, including in various subgroups.

News
August 13, 2020
1 min read
Save

Delay from symptom onset to IPF diagnosis often longer than 1 year

Delay from symptom onset to IPF diagnosis often longer than 1 year

In the IPF-PRO Registry, 50% of patients had a delay of longer than 1 year between symptom onset and diagnosis of idiopathic pulmonary fibrosis.

View more